《衰老神經科學前沿》是一本前沿的多學科期刊，旨在促進對中樞神經系統衰老和與年齡相關的神經疾病相關的機制過程的理解。該雜志的另一個核心作用是，將專注于理解衰老基本過程的學科和理論結合起來。特別強調整合神經科學各子學科的研究成果，對衰老過程和與衰老相關的神經系統疾病進行轉化研究，并制定旨在保護神經功能的治療策略。這方面對于提高我們理解、管理和治療與衰老相關的疾病的能力至關重要。由于該雜志的綜合性，將考慮的文章范圍是廣泛的，包括闡明遺傳、生物物理、基因組、蛋白質組、細胞、分子、生化、內分泌、免疫學、生理學、藥理學和心理/行為方面的CNS老化和神經系統疾病和病理事件與此過程相關的工作。也歡迎針對神經老化/疾病機制方面的神經影像學研究和臨床研究。提交作者須知對于涉及動物和人類衰老和年齡相關神經系統疾病領域的機械和介入研究的基礎研究(神經影像學臨床試驗、年齡相關疾病的生物標志物或延遲年齡干預措施)，請在求職信中注明，您提交的材料將在我們的臨床前/轉化部門考慮。如果你的手稿包括臨床研究中樞神經系統related-related發生的變化與衰老和年齡相關的神經系統疾病(神經系統功能的變化,發生在整個壽命或比較和正常年齡中樞神經系統病變的功能),請注明你提交的求職信的目的是為臨床部門。

Frontiers in Aging Neuroscience is a cutting-edge multidisciplinary journal aimed at fostering the understanding of mechanistic processes associated with CNS aging and age-related neuronal diseases. Another central role of the journal is to bring cohesion between disciplines and theories focused on understanding the fundamental processes of senescence. Special emphasis is placed on integrating findings of various sub disciplines in neuroscience to yield translational insight to the aging process and neurological diseases associated with senescence, and developing treatment strategies aimed at the conservation of neuronal function. This aspect is critical to advance our ability to understand, manage, and treat conditions associated with aging. Because of the integrative nature of the journal, the scope of articles that will be considered is broad, and includes work elucidating genetic, biophysical, genomic, proteomic, cellular, molecular, biochemical, endocrinal, immunological, physiological, pharmacological, and psychological/behavioral aspects of CNS aging and neurological diseases and pathological events connected to this process. Neuroimaging studies and clinical studies targeted to mechanistic aspects of neuronal aging/disease are also welcome.Instructions for Submitting AuthorsFor basic research involving mechanistic and intervention-based studies within the field of aging and age-related neurological diseases in animals and humans (clinical trials with neuroimaging, biomarkers for age-related disease or age-delaying interventions), please indicate in the cover letter that your submission is intended for consideration within our pre-clinical/translational division. If your manuscript involves clinical research on CNS related-related changes that occur with aging and age-related neurological diseases (changes in neurological function that occur across the lifespan or comparisons and normal aged to diseased CNS function), please indicate in the cover letter that your submission is intended for our clinical division.